NCT02072148View on ClinicalTrials.gov

The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL)

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 12, 2022

Study Completion Date

May 12, 2022

Conditions
Human Papilloma VirusOropharyngeal Squamous Cell Carcinoma
Interventions
PROCEDURE

PET/CT

PET scan or CT scan q 4 months for 5 years

RADIATION

Radiotherapy

Postoperative XRT 5000 cGy

RADIATION

Concurrent Chemoradiation

"CCRT with cisplatin 40mg/m2/week IV over approximately 30 minutes, mixed in 250ml normal saline Weekly on Monday or Tuesday any time, or Wednesday prior to radiation~Postoperative XRT 5000 cGy"

RADIATION

Concurrent Chemoradiation

"CCRT with cisplatin 40mg/m2/week IV over approximately 30 minutes, mixed in 250ml normal saline Weekly on Monday or Tuesday any time, or Wednesday prior to radiation~Postoperative XRT 5600 cGy"

Trial Locations (2)

10003

Mount Sinai Beth Israel, New York

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02072148 - The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) | Biotech Hunter | Biotech Hunter